drugset / Trial / NCT02902978

A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects

NCT02902978 ↗

Phase 1 Completed 56 enrolled EA Pharma Co., Ltd.
RandomizedParallel-groupDouble-blindBasic science

Summary

The primary purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of a single dose of E6130 in Japanese healthy adult male participants.

Timeline

Start
2016-09-26
Primary completion
2017-08-17
Completion
2017-08-17

Drugs

EvaluationDrugModalityDoseRoute
Subject E6130 Unknown — —

Indications

No indication recorded.